Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases

Molecular and Cellular Proteomics

Volumn 7, Issue 5, 2008, Pages 853-863

  Pierce, Andrew ^a   Unwin, Richard D ^a   Evans, Caroline A ^a   Griffiths, Stephen ^a   Carney, Louise ^a   Zhang, Liqun ^a   Jaworska, Ewa ^a   Lee, Chia Fang ^a   Blinco, David ^a   Okoniewski, Michal J ^b   Miller, Crispin J ^b   Bitton, Danny A ^b   Spooncer, Elaine ^a   Whetton, Anthony D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD135 ANTIGEN; HYBRID PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KIT; PROTEIN NPM ALK; PROTEIN TYROSINE KINASE; PROTEOME; RIBONUCLEASE; TRANSCRIPTOME; VIMENTIN; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; CELL LINE; CHEMOTAXIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; ENZYME ACTIVITY; EXON; LEUKEMIA; LIQUID CHROMATOGRAPHY; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; METHODOLOGY; MOUSE; PROTEIN SYNTHESIS;

ANIMALS; CELL LINE; CHEMOTAXIS; EXONS; GENE EXPRESSION PROFILING; LEUKEMIA; MASS SPECTROMETRY; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; PROTEOME; PROTEOMICS;

EID: 43849113605     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M700251-MCP200     Document Type: Article

References (38)

1. Mitelman, F., Johansson, B., and Mertens, F. (2007) The impact of translocations and gene fusions on cancer causation. Nat Rev. Cancer 7, 233-245
2. Konopka, J. B., Watanabe, S. M., and Witte, O. N. (1984) An alteration of the human c-Abl protein in K562 leukemia-cells unmasks associated tyrosine kinase-activity. Cell 37, 1035-1042
3. Golub, T. R., Barker, G. F., Lovett, M., and Gilliland, D. G. (1994) Fusion of PDGF receptor-β to a novel Ets-like gene, Tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77, 307-316
4. Cools, J., DeAngelo, D. J., Gotlib, J., Stover, E. H., Legere, R. D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J. D., Cross, N. C. P., Tefferi, A., Malone, J., Alam, R., Schrier, S. L., Schmid, J., Rose, M., Vandenberghe, P., Verhoef, G., Boogaerts, M., Wlodarska, I., Kantalian, H., Marynen, P., Coutre, S. E., Stone, R., and Gilliland, D. G. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N. Engl. J. Med. 348, 1201-1214
5. Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L, and Look, A. T. (1994) Fusion of a kinase gone, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263, 1281-1284
6. Negata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S., Suzuki, Y., and Metcalfe, D. D. (1995) Identification of a point mutation in the catalytic domain of the protooncogene c-Kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc. Natl. Acad. Sci. U. S. A. 92, 10560-10564
7. Nakao, M., Yokota, S., Iwai, T., Kaneko, H., Honike, S., Kashima, K., Sonoda, Y., Fujimoto, T., and Misawa, S. (1996) Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 10, 1911-1918
8. Baselga, J. (2006) Targeting tyrosine kinases in cancer the second wave. Science 312, 1175-1178
9. Deininger, M., Buchdunger, E., and Druker, B. J. (4005) The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105, 2640-2653
10. Hochhaus, A., Kantarjian, H. M., Baccarani, M., Lipton, J. H., Apperley, J. F., Druker, B. J., Facon, T., Goldberg, S. L, Cervantes, F., Niederwieser, D., Silver, R. T., Stone, R. M., Hughes, T. P., Muller, M. C., Ezzeddine, R., Countouriotis, A. M., and Shah, N. P. (2007) Dasatinib induces notable hematologic and cytogeneic responses in chronic-phase chronic myeloid leukemia after failure Of imatinib therapy. Blood 109, 2303-2309
11. Unwin, R. D., Smith, D. L., Blinco, D., Wilson, C. L., Miller, C. J., Evans, C. A., Jaworska, E., Baldwin, S. A., Barnes, K., Pierce, A., Spooncer, E., and Whetton, A. D. (2006) Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoletic stem cells. Blood 107, 4687-4694
12. Unwin, R. D., Pierce, A., Watson, R. B., Sternberg, D. W., and Whetton, A. D. (2005) Quantitative proteomic analysis using isobaric protein tags enables rapid comparison of changes in transcript and protein levels in transformed cells. Mol. Cell. Proteomics 4, 924-935
13. Ross, P. L., Huang, Y. L N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3, 1154-1169
14. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y. C., Gentry, J., Homik, K., Hothom, T., Huber, W., lacus, S., Irizarry, R., Leisch, F., Li, C., Maechler, M., Rossini, A. J., Sawitzki, G., Smith, C., Smyth, G., Tierney, L., Yang, J. Y. H., and Zhang, J. H. (2004) Bioconductor open software development for computational biology and bioinformatics. Genome Biol. 5, R80
15. Irizarry, R. A., Bolstad, B. M., Collin, F., Cope, L. M., Hobbs, B., and Speed, T. P. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31, e15
16. Okoniewski, M. J., Yates, T., Dibben, S., and Miller, C. J. (2007) An annotation infrastructure for the analysis and interpretation of Affymetrix exon array data. Genome Biol. 8, R79
17. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate - a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289-300
18. Hubbard, T. J. P., Aken, B. L, Beal, K., Ballester, B., Caccamo, M., Chen, Y., Clarke, L., Coates, G., Cunningham, F., Cutts, T., Down, T., Dyer, S. C., Fitzgerald, S., Fernandez-Banet, J., Graf, S., Haider, S., Hammond, M., Herrero, J., Holland, R., Howe, K., Howe, K., Johnson, N., Kahari, A., Keefe, D., Kokocinski, F., Kulesha, E., Lawson, D., Longden, I., Melsopp, C., Megy, K., Meidl, P., Overduin, B., Parker, A., Prlic, A., Rice, S., Rios, D., Schuster, M., Sealy, I., Severin, J., Slater; G., Smedley, D., Spudich, G., Trevanion, S., Vilella, A., Vogel, J., White, S., Wood, M., Cox, T., Curwen, V., Durbin, R., Fernandez-Suarez, X. M., Flicek, P., Kasprzyk, A., Proctor, G., Searle, S., Smith, J., Ureta-Vidal, A., and Birney, E. (2007) Ensembl 2007. Nucleic Acids Res. 35, D610-D617
19. Shilov, I. V., Seymour, S. L., Patel, A. A., Loboda, A., Tang, W. H., Keating, S. P., Hunter, C. L, Nuwaysir, L M., and Schaeffer, D. A. (2007) The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell. Proteomics 6, 1638-1655
20. ΔΔCT method. Methods 25, 402-408
21. Whetton,A. D., Lu, Y. N., Pierce, A., Carney, L., and Spooncer, E. (2003) Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1. Blood 102, 2798-2802
22. Dai, Z. H., Quackenbush, R. C., Courtney, K. D., Grove, M., Cortez, D., Reuther, G. W., and Pendergast, A. M. (1998) Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes Dev. 12, 1415-1424
23. Witke, W., Li, W., Kwiatkowski, D. J., and Southwick, F. S. (2001) Comparisons of CapG and gelsolin-null macrophages: demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing. J. Cell Biol. 154, 775-784
24. Evans, C. A., Tonge, R., Blinco, D., Pierce, A., Shaw, J., Lu, Y. N., Hamzah, H. G., Gray, A., Downes, C. P., Gaskell, S. J., Spooncer, E., and Whetton, A. D. (2004) Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility. Blood 103, 3751-3759
25. Neviani, P., Santhanam, R., Trotta, R., Notari, M., Blaser, B. W., Liu, S. J., Mao, H., Chang, J. S., Galietta, A., Uttam, A., Roy, D. C., Valtieri, M., Bruner-Kilsovic, R., Caligiuri, M. A., Bloomfield, C. D., Marcucci, G., and Perrotti, D. (2005) The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein. Cancer Cell 8, 355-368
26. Perrotti, D., and Neviani, P. (2006) ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia. Br. J. Cancer 95, 775-781
27. Hamzah, H. G., Pierce, A., Stewart, W. A., Downes, C. P., Gray, A., Irvine, A., Spooncer, E., and Whetton, A. D. (2005) Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (Ptdlns(3,4,5)P-3 and lack a Ptdlns(3,4,5)P-3 response to cytokines and chemotactic factors; effects reversed by imatinib. Leukemia 19, 1851-1853
28. Pierce, A., Lu, Y. M., Hamzah, H. G., Thompson, S., Owen-Lynch, P. J., Whetton, A. D., and Spooncer, E. (2006) Differential effect of leukaemogenic tyrosine kinases on cell motility is governed by subcellular localisation. Br. J. Haematol. 133, 345-352
29. Correll, P. H., Paulson, R. F., and Wei, X. (2006) Molecular regulation of receptor tyrosine kinases in hematopoietic malignancies. Gene (Amst.) 374, 26-38
30. Cilloni, D., Messa, E., Messa, F., Carturan, S., Defilippi, I., Arruga, F., Rosso, V., Catalano, R., Bracco, E., Nicoll, P., and Saglio, G. (2006) Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes. Ann. N. Y. Acad. Sci. 1089, 411-423
31. Delhommeau, F., Pisani, D. F., James, C., Casadevall, N., Constantinescu, S., and Vainchenker, W. (2006) Oncogenic mechanisms in myeloproliferative disorders. CMLS Cell. Mol. Life Sci. 63, 2939-2953
32. Penserga, E. T. P., and Skorski, T. (2007) Fusion tyrosine kinases: a result and cause of genomic instability. Oncogene 26, 11-20
33. Salgia, R., Li, J. L., Ewaniuk, D. S., Pear, W., Pisick, E., Burky, S. A., Ernst, T., Sattler, M., Chen, L. B., and Griffin, J. D. (1997) BCR/ ABL induces multiple abnormalities of cytoskeletal function. J. Clin. Investig. 100, 46-57
34. Perrotti, D., and Calabretta, B. (2004) Translational regulation by the p210 BCR/ABL oncoprotein. Oncogene 23, 3222-3229
35. Calabretta, B., and Perrotti, D. (2004) The biology of CML blast crisis. Blood 103, 4010-4022
36. Warmuth, M., Kim, S., Gu, X. J., Xia, G., and Adrian, F. (2007) Ba/F3 cells and their use in kinase drug discovery. Curr. Opin. Oncol. 19, 55-60
37. Mikesch, J. H., Schier, K., Roetger, A., Simon, R., Buerger, H., and Brandt, B. (2006) The expression and action of decay-accelerating factor (CD55) in human malignancies and cancer therapy. Cell. Oncol. 28, 223-232
38. Wolf-Yadlin, A., Hautaniemi, S., Lauffenburger, D. A., and White, F. M. (2007) Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl. Acad. Sci. U. S. A. 104, 5860-5865